RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery).
نویسندگان
چکیده
*Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK; ySalford Royal Hospitals NHS Trust, Salford M6 8HD, UK; zChristie Hospital NHS Trust, Manchester M20 4BX, UK; xDepartment of Oncology, UCH, 250 Euston Road, London NW1 2PQ, UK; kPrincess Margaret Hospital, 610 University Avenue, Toronto, ON, Canada M5G 2M9; {Department of Urology, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK; **MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, UK; yyUniversity of Ottawa, The Ottawa Hospital General Campus, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6; zzNational Cancer Institute of Canada (NCIC) Clinical Trials Group, 10 Stuart Street, Kingston, Ontario, Canada K7L 3N6; xxPCaSO Prostate Cancer Network, PO Box 66, Emsworth, Hampshire PO10 7ZP, UK
منابع مشابه
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy.
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): A new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy Chris Parker, Matthew R. Sydes 1 , Charles Catton 2 , Howard Kynaston 3 , John Logue , Claire Murphy 1 , Rachel C. Morgan 1 , Kilian Mellon 5 , Chris Morash 6 , Wendy Parulekar 7 ...
متن کاملThe role of radiation therapy in prostate cancer after radical prostatectomy: when and why?
PURPOSE OF REVIEW Recent data support postoperative radiotherapy in the management of selected patients with localized prostate cancer; however, optimal patient selection and timing of additional treatment are uncertain. Data describing selection factors for treatment and literature supporting immediate or delayed radiotherapy are reviewed and the limitations of current knowledge are discussed....
متن کاملContemporary management of prostate cancer with lethal potential.
Screening for prostate cancer by determining serum prostate-specific antigen (PSA) levels has resulted in a stage migration such that patients with high-risk disease are more likely to be candidates for curative local therapy. By combining serum PSA, clinical stage, and biopsy information--both Gleason score and volume of tumor in the biopsy cores--specimen pathologic stage and patient biochemi...
متن کاملLocally advanced and high risk prostate cancer: The best indication for initial radical prostatectomy?
High risk prostate cancer is a deadly disease that needs aggressive treatment. High risk prostate cancer is often treated with androgen deprivation therapy or combined radiohormonotherapy while there is a place for surgery in cases of operable and resectable locally advanced or high risk disease. This review summarises the results of the different treatment strategies for locally advanced and h...
متن کاملMortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
PURPOSE Androgen deprivation therapy is often used as salvage treatment in men with rising prostate specific antigen after initial radical prostatectomy or radiotherapy for clinically localized prostate cancer. Given the lack of evidence from general practice, we examined the association of salvage androgen deprivation therapy with mortality in an observational cohort study. MATERIALS AND MET...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical oncology (Royal College of Radiologists (Great Britain))
دوره 19 3 شماره
صفحات -
تاریخ انتشار 2007